Connect with us

Technology

Bulletin from the annual general meeting in Truecaller AB on 23 May 2025

Published

on

STOCKHOLM, May 23, 2025 /PRNewswire/ — Today, on 23 May 2025, the annual general meeting was held in Truecaller AB. A summary of the adopted resolutions follows below.

Resolution on adoption of accounts and distribution of the company’s result

The annual general meeting resolved to adopt the income statement and balance sheet as well as the consolidated income statement and consolidated balance sheet. The annual general meeting also resolved to allocate the company’s result in accordance with the proposal from the board of directors, meaning that a dividend of SEK 1.70 shall be paid per series A share and series B share, and that the remaining available funds shall be carried forward. It was further resolved that the record date for the dividend shall be 27 May 2025.

Discharge from liability for the board members and the chief executive officer

The annual general meeting resolved to discharge the board members and the chief executive officer from liability for the financial year 2024.

Election and remuneration of the board of directors and auditors

The annual general meeting resolved in accordance with the proposal from the Nomination Committee to re-elect Alan Mamedi, Annika Poutiainen, Helena Svancar, Nami Zarringhalam and Shailesh Lakhani as board members, and to elect Aruna Sundararajan as new board member. Nami Zarringhalam was re-elected as chairman of the board of directors.

Furthermore, the annual general meeting resolved that remuneration to the board shall be paid with SEK 650,000 to the chairman of the board of directors and with SEK 500,000 to each of the other board members. The annual general meeting further resolved that remuneration for committee work shall be paid with SEK 250,000 to the chairman of the Audit Committee, with SEK 100,000 to each of the other members of the Audit Committee, with SEK 150,000 to the chairman of the Remuneration Committee and with SEK 80,000 to each of the other members of the Remuneration Committee.

Finally, the annual general meeting resolved to re-elect Ernst & Young AB as auditor and that the auditor shall be paid in accordance with customary norms and approved invoice. Ernst & Young AB has informed that the authorized public accountant Jennifer Rock-Baley will continue to be the auditor in charge.

Resolution on approval of remuneration report

The annual general meeting resolved to approve the board of directors’ remuneration report for the financial year 2024.

Resolution on guidelines for remuneration to senior executives

The annual general meeting resolved in accordance with the proposal from the board of directors to adopt new guidelines for remuneration to the company’s senior executives.

Resolution on establishment of principles for the Nomination Committee

The annual general meeting resolved in accordance with the proposal from the Nomination Committee on the establishment of principles for the Nomination Committee. The Nomination Committee shall consist of representatives for the three largest shareholders or groups of shareholders in terms of votes as of 30 September 2025.

Resolution on authorization for the board of directors regarding issues

The annual general meeting resolved in accordance with the proposal from the board of directors to authorize the board of directors, at one or several occasions, during the time up until the next annual general meeting, with or without deviation from the shareholders’ preferential rights, and with or without provisions regarding payment in kind or through set-off or other provisions, to resolve to issue new series B shares, convertibles and/or warrants entitling to conversion or subscription of series B shares. The total number of series B shares that may be issued (alternatively be issued through conversion of convertibles and/or exercise of warrants) shall not exceed 38,792,638, which corresponds to a dilution of approximately ten (10) per cent calculated on the number of shares issued at the time of the annual general meeting. To the extent an issue is made with deviation from the shareholders’ preferential rights, the subscription price shall be on market terms (subject to customary new issue discount, as applicable). The purpose of the authorization is to be able to carry out and finance acquisitions of companies and assets and to give the board of directors increased room for maneuver and the opportunity to adapt and improve the company’s capital structure.

Resolution on authorization for the board of directors regarding repurchase and transfer of series B shares in the company

The annual general meeting resolved in accordance with the proposal from the board of directors to authorize the board of directors, at one or several occasions, during the time up until the next annual general meeting, to resolve on repurchase and transfer of series B shares in the company. Repurchase of series B shares may be made of a maximum number of shares so that the company’s shareholding does not, at each time, exceed ten (10) percent of all outstanding shares in the company. Repurchase of series B shares on Nasdaq Stockholm may be made at a price per share within the registered price interval of the company’s series B share at any time, or if the board of directors instructs a member of Nasdaq Stockholm to accumulate a specific number of the company’s shares for its own account during a limited period, at a price per share within the price interval at the time or an equivalent volume-weighted average price. Payment of the series B shares shall be made in cash.

Transfer of series B shares may be made of the total number of shares held by the company from time to time. Transfer may be made with deviation from the shareholders’ preferential rights on Nasdaq Stockholm. Transfer may also be made to third parties in connection with acquisition of companies, operations, or assets. Transfer of series B shares on Nasdaq Stockholm may only be made at a price per share within the registered price interval of the company’s share at the time and if the transfer is made in another way, at a price corresponding to prices in money or value of property received that corresponds to the price of the company’s series B share at the time of the transfer of the shares being transferred with the deviation considered appropriate by the board of directors. Transfer in connection with acquisitions may be made at a market value assessed by the board of directors. Payment for transferred series B shares can be made in cash, through an issue in kind or set-off.

The purpose of the authorizations is to give the board of directors the opportunity to continuously adapt the company’s capital structure and thereby contribute to increased shareholder value, to be able to exploit attractive acquisition opportunities by fully or partly financing future acquisitions of companies, operations, or assets with the company’s own shares, and for financing and/or securing the delivery of series B shares in long-term incentive programs approved by the general meeting.

Resolution on (A) reduction of the share capital by way of cancellation of own shares, and (B) increase of the share capital by way of bonus issue

The board of directors resolved, at the annual general meeting, to withdraw its proposal for (A) cancellation of the company’s own shares and (B) increase of the share capital through a bonus issue, due to the fact that the board of directors was informed prior to the annual general meeting that the hedging measures involving the issue and transfer of own shares in connection with the proposed share programmes will not achieve the required majority. The board of directors therefore considers that a larger holding of own series B shares is appropriate in order to increase the freedom of action in relation to the financing of the delivery of shares to the participants under the programmes.

Resolution on the implementation of a long-term share program 2025:1 and hedging arrangements in respect of the program

The annual general meeting resolved in accordance with the proposal from the board of directors on the implementation of a long-term share program 2025:1 as well as hedging arrangements in accordance with the below.

The share program shall comprise not more than 4,500,000 series B shares and include senior executives, key employees, and certain other employees in the Truecaller group.

In the share program, the participants are allocated a certain number of rights that entitle them to series B shares in the company after the end of a vesting period of two, three and four years, respectively. Following the vesting period, the participants will, free of charge, be allocated shares in the company. Allocation of shares presupposes, with certain limited exceptions, the participant to remain employed within the Truecaller group during the vesting period. In addition, a pre-requisite for the allocation of shares is that certain performance targets are fulfilled by Truecaller regarding revenue growth rate and adjusted EBITDA.

Upon maximum allotment of performance shares a maximum of 4,500,000 series B shares  can be issued, corresponding to approximately 1.3 percent of the total number of issued shares and approximately 0.6 percent of the total number of votes in the company

In order to secure delivery of shares to the participants in the share program, the annual general meeting further resolved on hedging measures by way of entering into an equity swap agreement with a third party on terms in accordance with market conditions, whereby the third party in its own name shall be entitled to acquire and transfer series B shares in the company to the participants of the share program.

Resolution on the implementation of a long-term share program 2025:2 and hedging arrangements in respect of the program

The annual general meeting resolved in accordance with the proposal from the board of directors on the implementation of a long-term share program 2025:2 as well as hedging arrangements in accordance with the below.

The share program shall comprise not more than 1,000,000 series B shares for the company’s newly appointed CEO, Rishit Jhunjhunwala.

In the share program, the participant is allocated a certain number of rights that entitle the participant to series B shares in the company after the end of a vesting period of at least approximately three years. Following the vesting period, the participant will, free of charge, be allocated shares in the company. Allocation of shares presupposes, with certain limited exceptions, the participant to remain as the CEO of Truecaller during the vesting period. In addition, a pre-requisite for the allocation of shares is that certain performance targets are fulfilled by Truecaller regarding revenue growth rate and adjusted EBITDA. 

Upon maximum allotment of performance shares a maximum of 1,000,000 series B shares can be issued, corresponding to approximately 0.3 percent of the total number of issued shares and approximately 0.1 percent of the total number of votes in the company.

In order to secure delivery of shares to the participant in the share program, the annual general meeting further resolved on hedging measures by way of entering into an equity swap agreement with a third party on terms in accordance with market conditions, whereby the third party in its own name shall be entitled to acquire and transfer series B shares in the company to the participant of the share program.

Stockholm on 23 May 2025
Truecaller AB (publ)

For more information, please contact:
Andreas Frid, Head of IR & Communication
+46 705 290800
andreas.frid@truecaller.com

This information was submitted for publication, through the agency of the contact person set out above, at the time stated by the Company’s news distributor, Cision, at the publication of this press release.

About Truecaller:
Truecaller (TRUE B) is the leading global platform for verifying contacts and blocking unwanted communication. We enable safe and relevant conversations between people and make it efficient for businesses to connect with consumers. Fraud and unwanted communication are endemic to digital economies. especially in emerging markets. We are on a mission to build trust in communication. Truecaller is an essential part of everyday communication for more than 450 million active users. Truecaller is listed on Nasdaq Stockholm since 8 October 2021. For more information. please visit corporate.truecaller.com.  

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/truecaller-ab/r/bulletin-from-the-annual-general-meeting-in-truecaller-ab-on-23-may-2025,c4154818

The following files are available for download:

https://mb.cision.com/Main/20429/4154818/3467808.pdf

Truecaller – Bulletin from Annual General Meeting 2025

View original content:https://www.prnewswire.com/news-releases/bulletin-from-the-annual-general-meeting-in-truecaller-ab-on-23-may-2025-302464218.html

SOURCE Truecaller AB

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Dario Announces Pricing of a $23.5 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

Published

on

By

The financing was led by continued support of existing long-term institutional investors along with participation from a new global fundamental institutional investor

NEW YORK, July 22, 2026 /PRNewswire/ — DarioHealth Corp. (NASDAQ: DRIO) (the “Company,” “DarioHealth” or “Dario”), a leading AI-powered healthcare technology company transforming the management of chronic conditions, today announced that it has entered into securities purchase agreements with current long term Dario institutional investors as well as new fundamental investors for the purchase and sale of 3,454,559 shares of common stock (or common stock equivalents in lieu thereof), at a price of $6.80 per share, in a registered direct offering priced at-the-market under Nasdaq rules (the “Offering”). A member of the Company’s Board of Directors participated in the Offering by purchasing 14,430 shares of the Company’s common stock at a purchase price of $6.93 per share. The gross proceeds from the Offering are expected to be approximately $23.5 million, before deducting placement agent fees and other estimated Offering expenses.

The closing of the offering is expected to occur on or about July 23, 2026, subject to the satisfaction of customary closing conditions. The Company intends to use the net proceeds from the offering for working capital, investments, acquisitions, and general corporate purposes. 

The Offering was priced at-the-market under Nasdaq rules. Existing long-term Dario institutional investors are participating alongside new fundamental investors, reflecting continued support for the Company’s strategic direction and ongoing business transformation into an AI-powered platform for the management of multiple chronic conditions.

A.G.P./Alliance Global Partners is acting as the sole placement agent for the offering.

The securities described above are being offered pursuant to an effective shelf registration statement on Form S-3 (File No. 333-294454) which became effective on March 27, 2026. The Offering is being made only by means of a prospectus which is part of the effective registration statement. A prospectus supplement and the accompanying prospectus relating to the Offering will be filed with the Securities and Exchange Commission (the “SEC”) and will be available on the SEC’s website located at http://www.sec.gov. Additionally, when available, electronic copies of the prospectus supplement and the accompanying prospectus may be obtained, when available, from A.G.P./Alliance Global Partners, 590 Madison Avenue, 28th Floor, New York, NY 10022, or by telephone at (212) 624-2060, or by email at prospectus@allianceg.com.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation, or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.

About DarioHealth Corp. (NASDAQ: DRIO)

DarioHealth Corp. (NASDAQ: DRIO) is an AI-powered healthcare technology company helping health plans, health systems and employers improve health outcomes while lowering the cost of care. The Company’s integrated platform combines connected devices, personalized member engagement, AI-driven insights and provider-backed clinical care to support people living with conditions including diabetes, hypertension, weight management, musculoskeletal and behavioral health needs.

Powered by more than 13 billion proprietary longitudinal healthcare data points collected over more than a decade, Dario’s AI platform personalizes care at the individual member level by analyzing biometric, clinical and behavioral data to deliver more timely and effective interventions. By combining engagement, clinical intelligence and care delivery within a single platform, Dario helps customers address multiple chronic conditions through one solution.

Cautionary Note Regarding Forward-Looking Statements

This news release and the statements of representatives and partners of DarioHealth Corp. related thereto contain or may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements that are not statements of historical fact may be deemed to be forward-looking statements. For example, the Company is using forward-looking statements in this press release when discussing the expected timing of the closing of the offering and the expected use of proceeds. Without limiting the generality of the foregoing, words such as “plan,” “project,” “potential,” “seek,” “may,” “will,” “expect,” “believe,” “anticipate,” “intend,” “could,” “estimate” or “continue” are intended to identify forward-looking statements. Readers are cautioned that certain important factors may affect the Company’s actual results and could cause such results to differ materially from any forward-looking statements that may be made in this news release. Factors that may affect the Company’s results include, but are not limited to, regulatory approvals, product demand, market acceptance, impact of competitive products and prices, product development, commercialization or technological difficulties, the success or failure of negotiations and trade, legal, social and economic risks, and the risks associated with the adequacy of existing cash resources. Additional factors that could cause or contribute to differences between the Company’s actual results and forward-looking statements include, but are not limited to, those risks discussed in the Company’s filings with the U.S. Securities and Exchange Commission. Readers are cautioned that actual results (including, without limitation, the timing for and results of the Company’s commercial and regulatory plans for Dario™ as described herein) may differ significantly from those set forth in the forward-looking statements. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.

DarioHealth Corporate Contacts
Michael Lipari
SVP Corporate Development
irteam@dariohealth.com
+1-201-785-6310

Rob Halpern
SVP Marketing
irteam@dariohealth.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/dario-announces-pricing-of-a-23-5-million-registered-direct-offering-of-common-stock-priced-at-the-market-under-nasdaq-rules-302832102.html

SOURCE DarioHealth Corp.

Continue Reading

Technology

Mattermost Launches Professional Certification for Engineers Operating Mission-Critical Communications Infrastructure

Published

on

By

Mattermost has launched its new Professional Certification, a high‑level credential designed for engineers, integrators, and administrators who deploy and operate Mattermost in mission‑critical, high‑security environments. Building on the strong adoption of the Associate Certification, the Professional tier validates advanced expertise in high‑availability architecture, identity integration, compliance, workflow automation, and operations in air‑gapped and classified networks. With early demand across defense, Federal, and enterprise sectors, this certification strengthens operational readiness, accelerates ATO timelines, and ensures organizations can confidently staff secure Mattermost deployments.

New Certification Tier Validates Advanced Deployment and Operational Expertise for Engineers in Defense, Federal and Security-Critical Environments

PALO ALTO, Calif., July 22, 2026 /PRNewswire-PRWeb/ — Six months after launching its first technical certification, Mattermost, the secure collaboration platform built for the world’s most critical operations, has certified hundreds of engineers across defense and federal governments – and today raises the bar with the launch of its Professional Certification tier — designed for engineers, integrators and administrators who deploy and operate Mattermost in defense, Federal and enterprise environments.

The Professional Certification builds on the Mattermost Associate Technical Certification, which launched in January 2026. Since launching, the Associate program has seen strong adoption with more than 125 engineers certified across partner and customer organizations, with engineers proudly sharing their credentials on LinkedIn as a signal of operational credibility in their markets.

The Professional tier validates the technical depth required to deploy and operate Mattermost in high-scale mission-critical environments, including high-availability architecture, identity integration, compliance controls and workflow automation for security-sensitive operations. Labs are hands-on and embedded directly in the learning environment. No other platform in this space offers this level of operational certification for air-gapped and classified environments.

“The Mattermost Certification Program reflects the operational standards our Government customers require to accomplish their missions,” said Corey Hulen, CEO of Mattermost Federal. “The environments they operate in don’t have a margin for error — when an engineer shows up to deploy or support Mattermost in a classified network or an air-gapped facility, they need to have already proven they can handle it. That’s not a nice-to-have. It’s a requirement.”

Designed for the Most Demanding Environments

Mattermost serves defense agencies, Federal departments and global enterprises that require communications infrastructure to operate where commercial cloud platforms cannot — including classified networks, air-gapped installations and disconnected forward operating environments. The Professional Certification reflects the operational standards these deployments require. For mission operators, that translates directly into operational readiness; faster Authority to Operate (ATO) timelines, reduced deployment risks, and a qualified talent pipeline that program offices cna hire and staff against with confidence.

The certification is available to SI and implementation partners and customer administrators managing production deployments. Early demand has been strong, with more than 25 organizations enrolling teams across defense, Federal and enterprise sectors enrolling teams in both the Associate and Professional programs.

“Carahsoft and our reseller partners are committed to connecting Government agencies with the innovative technologies they need to achieve their missions,” said Michael Shrader, Vice President of Intelligence and Innovative Solutions at Carahsoft. “The Mattermost Professional Certification Program helps ensure Public Sector organizations can confidently deploy and operate Mattermost in secure, high-performance environments.”

Availability

The Mattermost Professional Certification is available at certifications.mattermost.com. Engineers who have completed the Associate Technical Certification are encouraged to enroll directly. Experienced engineers may also attempt the Professional tier without the Associate prerequisite. Through Mattermost’s partnership with Carahsoft Technology Corp., The Trusted Government IT Solutions Provider®, its services are available through Government-approved contracts and Carahsoft’s reseller network.

Mattermost’s solutions are available through Carahsoft’s GSA Schedule No. 47QSWA18D008F, SEWP V contracts NNG15SC03B and NNG15SC27B, ITES-SW2 Contract W52P1J-20-D-0042, OMNIA Partners Contract #R240303 and The Quilt Master Service Agreement Number MSA05012019-F. For more information, contact the Carahsoft Team at (571) 662-4800 or Mattermost@carahsoft.com. Explore Mattermost’s solutions here.

About Mattermost

Mattermost is the secure, open-source collaboration platform built for technical teams in high-stakes, high-security environments. Trusted by defense agencies, government departments, and global enterprises, Mattermost is designed to operate where other platforms can’t — on-premises, air-gapped, and in the most demanding operational conditions on earth. Mattermost’s mission is to empower the people the world relies on. Learn more at mattermost.com.

Media contact:

Mattermost:

Rosa Lear

a-rosa.lear@mattermost.com

Media Contact

Rosa Lear, Mattermost, 1 4087574362, a-rosa.lear@mattermost.com, https://mattermost.com/

View original content to download multimedia:https://www.prweb.com/releases/mattermost-launches-professional-certification-for-engineers-operating-mission-critical-communications-infrastructure-302831659.html

SOURCE Mattermost

Continue Reading

Technology

Axcelis Announces Timing and Availability of Second Quarter 2026 Results and Conference Call

Published

on

By

BEVERLY, Mass., July 22, 2026 /PRNewswire/ — Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry will release financial results for the second quarter of 2026 before the opening of the market on Thursday, August 6, 2026.

The Company will host a call the same day to discuss the results at 8:30 a.m. ET. The call will be available via webcast that can be accessed through the Investors page of Axcelis’ website at www.axcelis.com, or by registering as a participant here: https://register-conf.media-server.com/register/BIf61211144e3b4baeb4c13ba3b1f529fa Webcast replays will be available for 30 days following the call.

About Axcelis:

Axcelis (Nasdaq: ACLS), headquartered in Beverly, Mass., has been providing innovative, high-productivity solutions for the semiconductor industry for over 45 years. Axcelis is dedicated to developing enabling process applications through the design, manufacture and complete life cycle support of ion implantation systems, one of the most critical and enabling steps in the IC manufacturing process. Learn more about Axcelis at www.axcelis.com.

CONTACTS:

Investor Relations Contact:
David Ryzhik
Senior Vice President and Interim CFO
Telephone: (978) 787-2352
Email: David.Ryzhik@axcelis.com

Press/Media Relations Contact: 
Maureen Hart
Senior Director, Corporate & Marketing Communications
Telephone: (978) 787-4266
Email: Maureen.Hart@axcelis.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/axcelis-announces-timing-and-availability-of-second-quarter-2026-results-and-conference-call-302831533.html

SOURCE Axcelis Technologies, Inc.

Continue Reading

Trending